Arachidonic + docosahexaenoic acid cuts risk for severe retinopathy of prematurity by nearly half
Short excerpt below. Click through to read at the original source.
Arachidonic acid (AA) and docosahexaenoic acid (DHA) decrease the risk for severe retinopathy of prematurity (ROP) in extremely preterm infants by nearly half, according to a research letter published online in JAMA Ophthalmology.